Skip to main content

Table 1 Patient characteristics

From: 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study

Parameter Median (range) n = 30 %
Age (years) 57.4 (36.9–78.9)  
Gender
 male   22 73
 emale 8 27
Body Mass Index (kg/m2) 23.2 (16.7–30.8)  
Charlson-comorbidity-Index
 2   23 77
 3–5 4 13
  > 6 3 10
ECOG score
 0   22 73
 1 8 27
Localization
 AEG Siewert Type II   12 40
 AEG Siewert Type III 10 34
 Gastric cancer 8 26
Grading
 G2   14 47
 G3 16 53
Laurén’s classification
 Intestinal   24 80
 Mixed 3 10
 Diffuse 3 10
uT-category
 uT2   4 13
 uT3 22 74
 uT4 4 13
cN-category
 cN0   3 10
 cN+ 27 90
cM-category
 cM0   24 80
 cM1 6 20
  1. Clinical TNM staging is based on EUS (uT) and/or CT or PET-CT (cN)